Works matching IS 2160763X AND DT 2022 AND VI 11 AND IP 5


Results: 13
    1

    Issue Information.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 557, doi. 10.1002/cpdd.827
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    Safety, Pharmacokinetics, and Pharmacodynamics of Etavopivat (FT‐4202), an Allosteric Activator of Pyruvate Kinase‐R, in Healthy Adults: A Randomized, Placebo‐Controlled, Double‐Blind, First‐in‐Human Phase 1 Trial.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 654, doi. 10.1002/cpdd.1058
    By:
    • Forsyth, Sanjeev;
    • Schroeder, Patricia;
    • Geib, James;
    • Vrishabhendra, Leela;
    • Konstantinidis, Diamantis G.;
    • LaSalvia, Kari;
    • Ribadeneira, Maria D.;
    • Wu, Eric;
    • Kelly, Patrick;
    • Kalfa, Theodosia A.
    Publication type:
    Article
    8

    Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors.

    Published in:
    Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 585, doi. 10.1002/cpdd.1052
    By:
    • Arkenau, Hendrik‐Tobias;
    • Taylor, Donatienne;
    • Xu, Xiaoying;
    • Chitnis, Shripad;
    • Llacer‐Perez, Casilda;
    • Moore, Kathleen;
    • Nidamarthy, Prasanna Kumar;
    • Ilankumaran, Palanichamy;
    • De Vos‐Geelen, Judith
    Publication type:
    Article
    9
    10
    11
    12
    13